Baranowski Lyn — SEC insider filings

SEC reporting owner CIK 1893640. 4 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2021-11-12 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Avalyn Pharma Inc. (AVLN)Chief Executive Officer, Director2—5 legs · 52,500 sh · $1,461,4575
Rani Therapeutics Holdings, Inc. (RANI)Director2——2

Insider filings — Baranowski Lyn

FiledFormIssuerReported transactionsSource
2026-11-194Avalyn Pharma Inc. (AVLN)Option exercise (M): 45,300 @ $4.62 · Sale (S): 39,600 @ $27.76 · Sale (S): 5,300 @ $28.15 · Sale (S): 400 @ $29.22 · Option exercise (M): 7,200 @ $4.62 · Sale (S): 6,465 @ $27.90 · +3 moreEDGAR
2026-05-014Avalyn Pharma Inc. (AVLN)Grant/award (A): 501,033 (derivative) @ $0EDGAR
2022-05-274Rani Therapeutics Holdings, Inc. (RANI)Grant/award (A): 22,240 (derivative) @ $0EDGAR
2021-11-124Rani Therapeutics Holdings, Inc. (RANI)Grant/award (A): 31,695 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1893640 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs